製品名:5-Bromo-3-methyl-2-(methylthio)pyrimidin-4(3H)-one

IUPAC Name:5-bromo-3-methyl-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one

CAS番号:81560-06-7
分子式:C6H7BrN2OS
純度:97%
カタログ番号:CM544275
分子量:235.1

包装単位 有効在庫 価格(USD) 数量
CM544275-100mg in stock ưƄƞ
CM544275-250mg in stock ƄȎȀ
CM544275-1g in stock ȀŢǯ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:81560-06-7
分子式:C6H7BrN2OS
融点:-
SMILESコード:O=C1N(C)C(SC)=NC=C1Br
密度:
カタログ番号:CM544275
分子量:235.1
沸点:
MDL番号:
保管方法:2-8°C,stored under nitrogen

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Vimseltinib
Vimseltinib (DCC-3014) is a potent and highly selective oral CSF1R kinase inhibitor that selectively and effectively inhibits CSF1R by utilizing the unique characteristics of the switch control region that regulates kinase conformational activation. The key phase 3 MOTION study conducted by vimseltinib in patients with giant cell tumor of the tendon sheath (TGCT) has shown positive results, and it is expected to submit a listing application to the FDA and the European Union next year.

Related Products